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Background & Objectives: Discrepancies
in research funding may contribute to
stagnant survival rates in pancreatic ductal
adenocarcinoma (PDAC). Comparative
analyses of survival and funding statistics in
cancers with high mortality were performed to
quantify discrepancies and identify areas for
intervention.
Methods: The Surveillance, Epidemiology,
and End Results database was queried for
survival statistics. Funding data were obtained
from the National Cancer Institute (NCI).
Clinical trial data were obtained from www.

clinicaltrials.gov. Cancers with high mortality
were included for analyses.
Results: Since 1997, PDAC has received
lesser funding ($1.13 billion) than other
cancers such as breast ($9.46 billion), prostate
($4.46 billion), lung ($4.26 billion), and
colorectal ($4.08 billion). Similarly, fewer
clinical trials have been completed in PDAC
(n=680) compared to breast (n=2,077), lung
(n=2,046), prostate (n=1,134) and colorectal
(n=1,196) cancer. Despite this, since 1997,
NCI dollars invested in PDAC research
produced a greater return on investment
with regards to 5-year overall survival (5YOS) compared to breast, prostate, uterine,
melanoma, and ovarian cancer. Incremental
cost effectiveness analysis demonstrates that

millions (liver, non-Hodgkin’s lymphoma)
and billions (colorectal, lung) of dollars were
required for each additional 1% increase
in 5Y-OS compared to PDAC. Funding of
research towards early detection and diagnosis
of PDAC has decreased by 50% since 2007.
For nearly all cancers, treatment-related
research receives the highest percentage of
NCI funding.
Conclusions: Funding of PDAC research is
significantly less than other cancers despite
its higher mortality and greater potential to
improve 5Y-OS. Increased awareness and
lobbying are required to increase funding,
promote research and improve survival. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.015
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Introduction: Commercially-available
topical hemostats for minor hemorrhage
incurred during elective surgical procedures
are relatively expensive. We believe that
more economical synthetic hemostats
could be produced. Our objective here was
to compare the efficacy and toxicity of a
synthetic resorbable hemostatic bandage vs.
an analogous commercial product in a porcine
model of minor hemorrhage.

edge of the left lateral lobe, and test bandage
(macroporous polycaprolactone mesh, PCL;
N = 10) or oxidized regenerated cellulose
(ORC; Surgicel®, Ethicon®; N = 10) was
applied with manual pressure for 5 minutes.
Resuscitation then was performed with warm
LR (target MAP = 80% of preinjury), and
blood loss was measured 60 min after injury.
For the survival toxicity study, a similar
resection technique was employed (N = 6 for
each material), and necropsy was performed
at 30 days to evaluate for bandage toxicity
(subject growth, serum chemistry, histology).

Methods: For the nonsurvival efficacy
study, anesthetized domestic swine (boars,
3 months, 29-40 kg) underwent arterial/
venous line placement and splenectomy. A 1
x 8cm section of liver was resected from the

Results: Pre-injury weight, VS, and
laboratory testing did not differ among
groups. Resection mortality was zero. In
the efficacy study, there were no differences
between the PCL vs. ORC groups in blood

Program: General Surgery

loss or other post-injury variables (Table),
except that the resuscitation fluid volume in
the ORC group was greater. Other results
from the efficacy study not shown in the Table
include platelet counts and coagulation testing
(no significant differences). Other than minor
granuloma formation at the implantation site
with both PCL and ORC, the survival study
did not reveal any measurable toxicity.
Conclusion: The efficacy and toxicity of the
PCL test bandage vs. the ORC comparator
were not different in a porcine model of minor
hepatic hemorrhage. Based on projected costs
of production (not shown), the PCL bandage
could represent a lower-cost alternative to
ORC for the treatment of minor surgical
bleeding. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.016
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Background & Objectives: The sympathetic
nervous system is a master regulator of
homeostasis, and sympathetic dysfunction
is implicated in the pathophysiology of
cardiovascular, renal, and neurological
disease. Despite its widespread importance,
sympathetic nervous system outflow cannot be
assessed in a clinically useful way, negatively
impacting the assessment and treatment
of prevalent diseases. One such example
is the controversial pivotal trial failure of
renal denervation, a promising intervention-
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based therapy for hypertension in which the
renal sympathetic nerves are ablated by an
endovascular approach. The inability to assess
the sympathetic nervous system, and thus
adequate renal sympathetic nerve ablation,
remains an existential problem facing the field
of renal denervation.
Methods: Based on the fact that renal
sympathetic nerve activity exerts rhythmic,
baroreflex-driven, and vasoconstrictive
control of the renal vasculature, we developed
a novel technique for identifying rhythmic
sympathetic vascular control using a timevarying, two-component Windkessel model
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of the renal circulation. This technology was
tested in two different animal models of renal
denervation; ten rabbits underwent chronic,
surgical renal denervation, and nine pigs
underwent acute, functional renal denervation
via intrathecal administration of ropivacaine.
Results: Both methods of renal denervation
reduced low-admittance gain, negativephase shift renal vascular control at known
sympathetic vasomotor frequencies, consistent
with a reduction in vasoconstrictive,
baroreflex-driven renal sympathetic
vasomotion, but did not affect mean renal
blood flow.
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